查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417199

霍亂疫苗市場報告：2030 年趨勢、預測與競爭分析

Cholera Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

霍亂疫苗趨勢與預測

預計2030年，全球霍亂疫苗市場將達到1,553.8億美元，2024年至2030年年複合成長率為9.0%。該市場的主要驅動力是人們對霍亂預防的認知和承諾不斷增強、政府主導的努力以及為實現集體行動和通用目標而加強的全球合作。全球霍亂疫苗市場的未來看起來充滿希望，醫院和診所、研究機構和學術實驗室市場充滿機會。

霍亂疫苗市場洞察

Lucintel 預測，與霍亂弧菌 O1 相比，含有重組 b次單元的全細胞將在預測期內經歷最高的生長。

醫院和診所將繼續成為市場的最大部分。

預計北美地區在預測期內將出現最高的成長。

常問問題

Q.1 霍亂疫苗的市場規模有多大？

A1. 預計2030年，全球霍亂疫苗市場規模將達到1,553.8億美元。

Q.2 霍亂疫苗市場的成長預測為何：

A2. 2024年至2030年，全球霍亂疫苗市場預計將以9.0%的年複合成長率成長。

Q.3 影響霍亂疫苗市場成長的關鍵因素有哪些：

A3. 該市場的主要驅動力是人們對霍亂預防的認知和承諾不斷增強，政府主導的舉措和全球合作推動集體行動和朝著通用目標取得進展。

Q4.市場的主要細分市場是：

A4. 霍亂疫苗市場的未來看起來充滿希望，醫院和診所、研究和學術實驗室市場都有機會。

Q5.市場的主要企業是：

A5. 主要的霍亂疫苗公司如下。

  • Astellas Pharma
  • Celldex Therapeutics
  • Emergent BioSolutions
  • Eubiologics
  • Johnson &Johnson
  • Merck
  • Pfizer
  • PharmaChoice Canada
  • Sanofi
  • Takeda Pharmaceutical Company Limited

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，與霍亂弧菌 O1 相比，含有重組 b次單元的全細胞在預測期內將具有最高的生長速度。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 預計北美在預測期內將經歷最高的成長。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球霍亂疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球霍亂疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 按疫苗類型分類的全球霍亂疫苗市場
    • 霍亂弧菌 O1 與含有重組 b次單元的全細胞
    • 殺死口服 O1 和 O139
  • 全球霍亂疫苗市場（按產品）
    • 杜科拉爾
    • 山哲
    • 瓦克喬拉
    • Ubicol 和 Ubicol Plus
    • 其他
  • 按最終用途行業分類的全球霍亂疫苗市場
    • 醫院和診所
    • 研究與學術機構
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球霍亂疫苗市場區域分佈
  • 北美霍亂疫苗市場
  • 歐洲霍亂疫苗市場
  • 亞太霍亂疫苗市場
  • 其他地區霍亂疫苗市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按疫苗類型分類的全球霍亂疫苗市場成長機會
    • 全球霍亂疫苗市場成長機會（按產品）
    • 按最終用途產業分類的全球霍亂疫苗市場成長機會
    • 全球霍亂疫苗市場成長機會（按地區）
  • 全球霍亂疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球霍亂疫苗市場產能
    • 全球霍亂疫苗市場的併購、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • Astellas Pharma
  • Celldex Therapeutics
  • Emergent BioSolutions
  • Eubiologics
  • Johnson & Johnson
  • Merck
  • Pfizer
  • PharmaChoice Canada
  • Sanofi
  • Takeda Pharmaceutical Company Limited
簡介目錄

Cholera Vaccine Trends and Forecast

The future of the global cholera vaccine market looks promising with opportunities in the hospitals and clinics and research and academic laboratories markets. The global cholera vaccine market is expected to reach an estimated $155.38 billion by 2030 with a CAGR of 9.0% from 2024 to 2030. The major drivers for this market are growing awareness and efforts towards cholera prevention and government-driven initiatives and global collaborations are fostering collective action and progress towards common goals.

A more than 150-page report is developed to help in your business decisions.

Cholera Vaccine by Segment

The study includes a forecast for the global cholera vaccine by vaccine type, product, end use industry, and region.

Cholera Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

  • Whole Cell V. Cholerae O1 with Recombinant B-Subunit
  • Killed Oral O1 and O139

Cholera Vaccine Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Dukoral
  • Shanchol
  • Vaxchora
  • Euvichol and Euvichol-Plus

Cholera Vaccine Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Clinics
  • Research and Academic Laboratories
  • Others

Cholera Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cholera Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cholera vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cholera vaccine companies profiled in this report include-

  • Astellas Pharma
  • Celldex Therapeutics
  • Emergent Biosolutions
  • Eubiologics
  • Johnson & Johnson
  • Merck
  • Pfizer
  • Pharmachoice Canada
  • Sanofi
  • Takeda Pharmaceutical Company Limited

Cholera Vaccine Market Insights

Lucintel forecasts that whole cell v. cholerae O1 with recombinant b-subunit is expected to witness highest growth over the forecast period.

Within this market, hospitals and clinics will remain the largest segment.

North America is expected to witness highest growth over the forecast period.

Features of the Global Cholera Vaccine Market

Market Size Estimates: Cholera vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cholera vaccine market size by vaccine type, product, end use industry, and region in terms of value ($B).

Regional Analysis: Cholera vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different vaccine type, product, end use industry, and regions for the cholera vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cholera vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the cholera vaccine market size?

Answer: The global cholera vaccine market is expected to reach an estimated $155.38 billion by 2030.

Q.2 What is the growth forecast for cholera vaccine market?

Answer: The global cholera vaccine market is expected to grow with a CAGR of 9.0% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cholera vaccine market?

Answer: The major drivers for this market are growing awareness and efforts towards cholera prevention and government-driven initiatives and global collaborations are fostering collective action and progress towards common goals.

Q4. What are the major segments for cholera vaccine market?

Answer: The future of the cholera vaccine market looks promising with opportunities in the hospitals and clinics and research and academic laboratories markets.

Q5. Who are the key cholera vaccine market companies?

Answer: Some of the key cholera vaccine companies are as follows.

  • Astellas Pharma
  • Celldex Therapeutics
  • Emergent BioSolutions
  • Eubiologics
  • Johnson & Johnson
  • Merck
  • Pfizer
  • PharmaChoice Canada
  • Sanofi
  • Takeda Pharmaceutical Company Limited

Q6. Which cholera vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that whole cell v. cholerae O1 with recombinant b-subunit is expected to witness highest growth over the forecast period.

Q7. In cholera vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cholera vaccine market by vaccine type (whole cell V. cholerae O1 with recombinant B-subunit and killed oral O1 and O139), product (dukoral, shanchol, vaxchora, euvichol and euvichol-plus, and others), end use industry (hospitals and clinics, research and academic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cholera Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cholera Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cholera Vaccine Market by Vaccine Type
    • 3.3.1: Whole Cell V. Cholerae O1 with Recombinant B-Subunit
    • 3.3.2: Killed Oral O1 and O139
  • 3.4: Global Cholera Vaccine Market by Product
    • 3.4.1: Dukoral
    • 3.4.2: Shanchol
    • 3.4.3: Vaxchora
    • 3.4.4: Euvichol and Euvichol-Plus
    • 3.4.5: Others
  • 3.5: Global Cholera Vaccine Market by End Use Industry
    • 3.5.1: Hospitals and Clinics
    • 3.5.2: Research and Academic Laboratories
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cholera Vaccine Market by Region
  • 4.2: North American Cholera Vaccine Market
    • 4.2.2: North American Cholera Vaccine Market by End Use Industry: Hospitals and Clinics, Research and Academic Laboratories, and Others
  • 4.3: European Cholera Vaccine Market
    • 4.3.1: European Cholera Vaccine Market by Vaccine Type: Whole Cell V. Cholerae O1 with Recombinant B-Subunit and Killed Oral O1 and O139
    • 4.3.2: European Cholera Vaccine Market by End Use Industry: Hospitals and Clinics, Research and Academic Laboratories, and Others
  • 4.4: APAC Cholera Vaccine Market
    • 4.4.1: APAC Cholera Vaccine Market by Vaccine Type: Whole Cell V. Cholerae O1 with Recombinant B-Subunit and Killed Oral O1 and O139
    • 4.4.2: APAC Cholera Vaccine Market by End Use Industry: Hospitals and Clinics, Research and Academic Laboratories, and Others
  • 4.5: ROW Cholera Vaccine Market
    • 4.5.1: ROW Cholera Vaccine Market by Vaccine Type: Whole Cell V. Cholerae O1 with Recombinant B-Subunit and Killed Oral O1 and O139
    • 4.5.2: ROW Cholera Vaccine Market by End Use Industry: Hospitals and Clinics, Research and Academic Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cholera Vaccine Market by Vaccine Type
    • 6.1.2: Growth Opportunities for the Global Cholera Vaccine Market by Product
    • 6.1.3: Growth Opportunities for the Global Cholera Vaccine Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Cholera Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Cholera Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cholera Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cholera Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Astellas Pharma
  • 7.2: Celldex Therapeutics
  • 7.3: Emergent BioSolutions
  • 7.4: Eubiologics
  • 7.5: Johnson & Johnson
  • 7.6: Merck
  • 7.7: Pfizer
  • 7.8: PharmaChoice Canada
  • 7.9: Sanofi
  • 7.10: Takeda Pharmaceutical Company Limited